Nasdaq OMX Europe ("Neuro") today announced that Barclays Capital has been approved as a Sponsoring Participant.
Barclays Capital will be the first broker to offer Sponsored Access using NEURO's advanced Pre-Trade Risk Management system.
Sponsored Access enables participants to provide their clients' direct connectivity to NEURO's advanced matching and routing services. NEURO provides a Pre-Trade Risk Management system which mitigates market risk by monitoring all orders submitted to the NEURO book. Any orders that breach pre-determined trading limits will be rejected.
Clients are able to connect either via proximity hosting or through remote access.
"We are delighted to be working with Barclays Capital in providing their clients with access to NEURO," said Charlotte Crosswell, President of NEURO. "Sponsored Access provides new opportunities for a wide range of market participants to trade directly on our platform."
"We are pleased to be the first broker to offer our clients full-service sponsored access on NASDAQ OMX Europe" said Robert Orgel, Head of Barclays Capital's Quantitative Prime Services product in Europe. "As the European trading landscape evolves, we continue to work closely with trading venues in order to offer new and innovative solutions to our clients. Sponsored access complements our market leading DMA platform, SubM(SM), providing ultra low latency access to equities, futures and options markets globally."